Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAV-trial: Plerixafor and Vinorelbine for Stem Cell Mobilization in Myeloma
NCT01220375Phase 2Completed
- Sponsor
- Insel Gruppe
- Start
- Apr 2010
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of plerixafor in multiple myeloma (MM), sponsored by Insel Gruppe. Started Apr 2010; status: completed.
02
Drugs
plerixafor
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01220375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01220375.